LifeArc Gene Therapy Innovation Fund
Funds promising gene therapies for rare conditions through LifeArc's Gene Therapy Innovation Fund.
LifeArc administers the Gene Therapy Innovation Fund as a grant fund for promising gene therapies for people living with rare conditions. The official source states that GTIF is a GBP 5 million annual fund and that the funding panel reviews full applications and makes funding decisions twice a year.
The supplied facts do not state per-project award minimums, per-project caps, a current deadline, an application URL, or a scoring rubric. Treat the GBP 5 million figure as an annual fund pool described in prose, not a per-applicant cap, and verify current application instructions with LifeArc before applying.
Rare-condition gene therapy projects, including viral-vector manufacturing and translational work needed to advance promising therapies.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see the timeline
Sign up free to see where teams trip up